Statement of Deviation
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dev Labtech Venture Limited has filed a regulatory compliance statement under SEBI LODR Regulation 32 confirming there is no deviation or variation in the use of funds raised through its Public Issue of Equity Shares (allotted on 24 March 2023, raising Rs. 11.22 crore) and Preferential Issue of Share Warrants (allotted on 21 December 2023). The Rs. 11.22 crore from the Public Issue was fully deployed across Capital Expenditure (Rs. 1.54 crore), Working Capital (Rs. 7.50 crore), General Corporate Expenses (Rs. 1.78 crore), and Public Issue expenses (Rs. 40 lakh) as originally planned. The Preferential Issue, originally pegged at Rs. 22.27 crore based on full conversion of 35,92,000 warrants at Rs. 62 each, has received Rs. 19.67 crore so far, with 30,32,000 warrants already converted into equity shares and listing application for the remaining 5,60,000 shares already submitted to BSE. The Audit Committee reviewed the statement and raised no comments.
This is a routine, neutral-to-slightly-positive compliance filing that confirms the company has used its raised funds as promised to shareholders, with no misuse or diversion. It reinforces management credibility but is unlikely to move the share price on its own.